ESMO Open · 2017 · 123 citations · 11 references
Life SciencesImmunologyPathologyHepatologyImmunopathologyImmunotherapyCheckpoint Inhibitor TherapyHepatic ToxicityImmune Checkpoint InhibitorsImmune CheckpointsImmune-related Adverse EventsLiver DiseaseBiliary Tract InjuryCytotoxic T Lymphocyte-associated Protein 4 PathwayCytotoxic T-lymphocyte-associated Protein 4 InhibitorsImmune-mediated Hepatic InjuryImmune-mediated Liver InjuryLong-term ImmunosuppressionProgrammed Cell Death Protein 1 (Pd-1) PathwayProgrammed Cell Death Protein 1 Inhibitors
INTRODUCTION: Hepatotoxicity from T-cell checkpoint blockade is an increasingly common immune-related adverse event, but remains poorly characterised and can be challenging to manage. Such toxicity is generally considered to resemble autoimmune hepatitis, although this assumption is extrapolated from limited clinicopathological reports of anti-cytotoxic T-lymphocyte-associated protein 4-induced hepatotoxicity. METHODS: Here we report, with full clinicopathological correlation, three cases of T-cell checkpoint inhibitor-induced hepatotoxicity associated with anti-programmed cell death protein 1 agents. RESULTS: We find that a major feature of these cases is biliary injury, including a unique case of vanishing bile duct syndrome, and that such toxicity was poorly responsive to long-term immunosuppression (corticosteroids and mycophenolate mofetil). Any potential benefits of long-term immunosuppression in these cases were outweighed by therapy-related complications. DISCUSSION: We discuss potential aetiologies and risk factors for immune-mediated biliary toxicity in the context of the limited literature in this field, and provide guidance for the investigation and supportive management of affected patients.
11
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2015 · 8.1K citations · Full text
Ipilimumab associated hepatitis: imaging and clinicopathologic findings
Kyung Won Kim, Nikhil H. Ramaiya, Katherine M. Krajewski et al. · Investigational New Drugs · 2013 · 233 citations
Medicine, Immunology, Pathology +12
Ipilimumab-associated Hepatitis
Melanie Johncilla, Joseph Misdraji, Daniel S. Pratt et al. · The American Journal of Surgical Pathology · 2015 · 207 citations
Medicine, Immunology, Pathology +17